Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Synribo (omacetaxine mepesuccinate)
i
Other names:
sHHT, CGX-635, CXS-635, HHT, NCI 141633, C41443
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
ArchiMed, Teva
Drug class:
Apoptosis stimulant, MCL1 inhibitor, MYC inhibitor, Protein synthesis inhibitor, G1-S-specific cyclin-D1 inhibitor
Related drugs:
‹
lurbinectedin (11)
arsenic trioxide (6)
STA-4783 (5)
pelareorep (4)
GZ17-6.02 (3)
quaratusugene ozeplasmid (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
S63845 (17)
AZD5991 (5)
AMG 176 (3)
PRT1419 (2)
APG-3526 (1)
AT 101 (1)
ABBV-467 (0)
GS-9716 (0)
MIK665 (0)
Mcl-1 inhibitors (0)
TTX-810 (0)
TW-37 (0)
AMG 397 (0)
ONT-701 (0)
CYC202 (0)
GT19077 (14)
WB100 (3)
PLX51107 (2)
RRx-001 (2)
10058-F4 (1)
ICX-101 (1)
MYCi975 (1)
OMO-103 (1)
IDP-121 (0)
LMP744 (0)
MRX34 (0)
OTX-2002 (0)
MT-5111 (4)
moxetumomab pasudotox (2)
recombinant (2)
MT-0169 (1)
LCB01-0371 (1)
Imtox19/Imtox22 (0)
OXS-1550 (0)
SVC112 (0)
oportuzumab monatox (0)
minocycline (0)
RSO-021 (0)
lurbinectedin (11)
arsenic trioxide (6)
STA-4783 (5)
pelareorep (4)
GZ17-6.02 (3)
quaratusugene ozeplasmid (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
S63845 (17)
AZD5991 (5)
AMG 176 (3)
PRT1419 (2)
APG-3526 (1)
AT 101 (1)
ABBV-467 (0)
GS-9716 (0)
MIK665 (0)
Mcl-1 inhibitors (0)
TTX-810 (0)
TW-37 (0)
AMG 397 (0)
ONT-701 (0)
CYC202 (0)
GT19077 (14)
WB100 (3)
PLX51107 (2)
RRx-001 (2)
10058-F4 (1)
ICX-101 (1)
MYCi975 (1)
OMO-103 (1)
IDP-121 (0)
LMP744 (0)
MRX34 (0)
OTX-2002 (0)
MT-5111 (4)
moxetumomab pasudotox (2)
recombinant (2)
MT-0169 (1)
LCB01-0371 (1)
Imtox19/Imtox22 (0)
OXS-1550 (0)
SVC112 (0)
oportuzumab monatox (0)
minocycline (0)
RSO-021 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Chronic Myeloid Leukemia
No biomarker
Chronic Myeloid Leukemia
omacetaxine mepesuccinate
Sensitive: A1 - Approval
omacetaxine mepesuccinate
Sensitive
:
A1
omacetaxine mepesuccinate
Sensitive: A1 - Approval
omacetaxine mepesuccinate
Sensitive
:
A1
FLT3 mutation
Acute Myelogenous Leukemia
FLT3 mutation
Acute Myelogenous Leukemia
cytarabine + bortezomib + omacetaxine mepesuccinate
Sensitive: C3 – Early Trials
cytarabine + bortezomib + omacetaxine mepesuccinate
Sensitive
:
C3
cytarabine + bortezomib + omacetaxine mepesuccinate
Sensitive: C3 – Early Trials
cytarabine + bortezomib + omacetaxine mepesuccinate
Sensitive
:
C3
IDH2 mutation
Glioma
IDH2 mutation
Glioma
omacetaxine mepesuccinate
Sensitive: D – Preclinical
omacetaxine mepesuccinate
Sensitive
:
D
omacetaxine mepesuccinate
Sensitive: D – Preclinical
omacetaxine mepesuccinate
Sensitive
:
D
IDH1 mutation
Glioma
IDH1 mutation
Glioma
omacetaxine mepesuccinate
Sensitive: D – Preclinical
omacetaxine mepesuccinate
Sensitive
:
D
omacetaxine mepesuccinate
Sensitive: D – Preclinical
omacetaxine mepesuccinate
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login